Drug details
Caplyta (lumateperone capsules)
type of Serotonin-Dopamine Activity Modulators (SDAM)
Caplyta (lumateperone) is an atypical antipsychotic used to treat schizophrenia in adults.
The drug is often used to treat Schizophrenia .
This drug may have the following side effects:
- nausea,
- vomiting,
- dizziness,
- dry mouth,
- fatigue,
- drowsiness,
- increased creatine phosphokinase,
- increased liver transaminases, and
- decreased appetite
The following drugs are related to Caplyta, either as a replacement or used together:
- Abilify (aripiprazole)
- Abilify Maintena (aripiprazole extended-release injectable suspension)
- Abilify MyCite (aripiprazole tablets with sensor)
- Aristada (aripiprazole lauroxil extended-release injection)
- Aristada Initio (aripiprazole lauroxil injectable suspension)
- Saphris (asenapine sublingual tablets)
- Rexulti (brexpiprazole tablets)
- Clozaril (clozapine)
- Fanapt (iloperidone tablets)
- Geodon (ziprasidone)
- Invega (paliperidone)
- Invega Sustenna (paliperidone palmitate extended-release injectable suspension)
- Invega Trinza (paliperidone palmitate extended-release injectable suspension)
- Latuda (lurasidone hcl tablets for oral administration)
- Lybalvi (olanzapine and samidorphan tablets)
- Zyprexa (olanzapine)
- Zyprexa Relprevv (olanzapine extended release injectable suspension)
- Seroquel (quetiapine fumarate)
- Seroquel XR (quetiapine fumarate extended-release tablets)
- Risperdal (risperidone)
- Risperdal Consta (risperidone)
- Rykindo (risperidone)